Retrospective Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jul 7, 2021; 27(25): 3901-3912
Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3901
Table 1 Patient characteristics

30s (n = 120)
40s (n = 451)
50s (n = 1044)
P value1
P value2
P value3
P value4
Sex, male (%)55.056.865.70.7300.0010.0200.001
Co-morbidity (%)28.337.352.90.070< 0.001< 0.001< 0.001
Endocrine3.39.514.30.0280.0120.001< 0.001
CVD2.511.829.80.002< 0.001< 0.001< 0.001
Pulmonary5.83.56.30.2590.0310.8350.096
Other20.821.120.60.9560.8370.9510.979
ASA score (%)0.079< 0.001< 0.001< 0.001
147.540.830.4
250.856.366.3
302.02.4
400.20.1
5000.1
Unknown0.80.70.8
BMI, mean (kg/m2)23.223.323.70.8990.0230.1430.049
Tumor location (%)0.9750.0610.2680.126
Right-sided colon20.016.020.9
Left-sided colon21.729.027.7
Rectum55.853.450.0
Multiple2.51.61.5
CEA, median (ng/mL)1.82.52.10.4970.6150.1900.462
CA, median 19-9 (IU/mL)11.112.611.30.2150.5270.8870.781
Neoadjuvant treatment (%)26.725.515.30.795< 0.0010.002< 0.001
Preoperative complication (%)14.217.312.90.6780.9100.6370.883
Treatment3.37.85.80.3780.3270.7060.517